Comparability is not just analytical equivalence

Biologicals

Volumn 34, Issue 1 SPEC. ISS., 2006, Pages 45-47

  Lubiniecki, Anthony S ^a,b   Marcia Federici, M ^a  

^a GLAXOSMITHKLINE   (United States)

^b CENTOCOR INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEFACEPT; ALGLUCERASE; ALTEPLASE; BLOOD CLOTTING FACTOR 8; DEOXYRIBONUCLEASE; EFALIZUMAB; ERYTHROPOIETIN; ETANERCEPT; HEPATITIS B SURFACE ANTIGEN; HUMAN SERUM ALBUMIN; INFLIXIMAB; INSULIN; OMALIZUMAB; PALIVIZUMAB; RECOMBINANT BLOOD CLOTTING FACTOR 8; RECOMBINANT GROWTH HORMONE; RITUXIMAB; TRASTUZUMAB;

ANALYTIC METHOD; DRUG MANUFACTURE; DRUG PACKAGING; DRUG QUALITY; DRUG SAFETY; EDITORIAL; FIBRINOLYTIC THERAPY; HUMAN; HYPOGLYCEMIA; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; PRODUCT DEVELOPMENT;

EID: 33644527907     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2005.08.016     Document Type: Editorial

References (0)